drugset / Trial / NCT03583021
Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Male
RandomizedParallel-groupDouble-blindPrevention
Summary
The primary purpose of this study is to investigate the optimal Ce of remifentanil for preventing emergence cough following extubation during general anesthesia in male patients who are reversed with sugammadex or neostigmine.
Timeline
- Start
- 2018-06-25
- Primary completion
- 2018-10-31
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 50 ug/kg | Intravenous |
| Subject | Sugammadex | Other / unclassified | 3 mg/kg | Intravenous |
| Comparator | Glycopyrrolate | Small molecule | 10 ug/kg | Intravenous |